Back
Corcept Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
CORT
Corcept Therapeutics
Last Price:
$60.62
Seasonality Move:
8.24%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.97 | Sell |
| 20-day SMA: | 67.33 | Sell |
| 50-day SMA: | 59.49 | Buy |
| 200-day SMA: | 44.9 | Buy |
| 8-day EMA: | 63.75 | Sell |
| 20-day EMA: | 64.75 | Sell |
| 50-day EMA: | 61.31 | Sell |
| 200-day EMA: | 47.95 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 43.07 | Sell |
| Chaikin Money Flow: | 703542 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.62 - 70.5) | Sell |
| Bollinger Bands (100): | (48.58 - 63.48) | Buy |
Corcept Therapeutics Technical Analysis
| Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 60.58 while CORT 8-day simple moving average is 64.97, which is a Sell signal.
-
The stock price of CORT is 60.58 while Corcept Therapeutics 20-day SMA is 67.33, which makes it a Sell.
-
Corcept Therapeutics 50-day simple moving average is 59.49 while CORT share price is 60.58, making it a Buy technically.
-
CORT stock price is 60.58 and Corcept Therapeutics 200-day simple moving average is 44.90, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $60.58. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
6.4B
Price in USD:
60.58
Share Volume:
1.4M
Corcept Therapeutics 52-Week Range
52-Week High:
75.00
52-Week Low:
20.84
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 60.58 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 60.58 while CORT 8-day exponential moving average is 63.75, which is a Sell signal.
-
The stock price of CORT is 60.58 while Corcept Therapeutics 20-day EMA is 64.75, which makes it a Sell.
-
Corcept Therapeutics 50-day exponential moving average is 61.31 while CORT share price is 60.58, making it a Sell technically.
-
CORT stock price is 60.58 and Corcept Therapeutics 200-day simple moving average is 47.95, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.09 per share, an increase this year of $0.37 per share, and an increase next year of $1.90 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 0.54, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 43.07, which suggest Corcept Therapeutics is oversold
-
The Bollinger Bands (25) for Corcept Therapeutics is (61.62 - 70.5), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (48.58 - 63.48), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.